RecruitingNCT06374745

An Integrated Algorithm for Surgical Intervention in Chronic Lymphedema After Breast Cancer Treatment: The Basel Lymphedema Protocol


Sponsor

University Hospital, Basel, Switzerland

Enrollment

500 participants

Start Date

Jan 2, 2015

Study Type

OBSERVATIONAL

Conditions

Summary

The primary objective of the investigators is to develop an integrated algorithm for surgical treatment of chronic lymphedema after breast cancer surgery. This will be achieved by retrospectively analysing a subgroup of patients who had breast cancer-related surgery prior to lymphedema.


Eligibility

Inclusion Criteria5

  • status post breast cancer or status post another type of cancer or status post no cancer
  • chronic lymphedema - lymphedema lasting over three months - present prior to surgical treatment
  • one type of surgical procedure for treatment of chronic lymphedema or a combination of surgical procedures for treatment of chronic lymphedema was performed
  • one or any combination of the following surgical procedures was used in each individual patient: Lymph Node-Vein Anastomosis (LNVA) , Lymphaticovenous Anastomosis (LVA), Tumescent Liposuction (TL), Vascularized Lymph Node Transfer (VLNT) and/or Water-Assisted Liposuction (WAL)
  • loss to follow-up (data not successfully collected)

Locations(1)

University Hospital Basel

Basel, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06374745


Related Trials